The pharmaceutical giant, whose China chief is now under investigation, was previously at the centre of insurance scam cases, ...

Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...

Astra saw £14.4bn wiped off its value after Chinese media said dozens of managers were implicated in a scandal.

AstraZeneca Plc said its experimental obesity pill was well tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines. The ...

The global market for peptide therapies is projected to grow at an outstanding compound annual growth rate (CAGR) of 10.8% ...

The global oral solid dosage pharmaceutical formulation market is poised for remarkable expansion, with projections indicating a growth from USD 629,582.6 million in 2024 to USD 895,636.0 million by ...

AstraZeneca stock tumbles as Chinese probe widens, implicating executives in insurance fraud and drug import violations ...

AstraZeneca may be emphasizing the potential for combination treatments to help its obesity pipeline stand out from the crowd, but the Big Pharma insists it is still “playing to win” in the space.

Pharmaceutical giant AstraZeneca said that the head of its China operations had been detained, after reports the firm was ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A spokesman said the president of its China business Leon Wang is co-operating with an investigation by Ch.inese authorities.

BEIJING—An investigation involving a top executive at drugmaker AstraZeneca AZN-8.40%decrease; red down pointing triangle is the latest to rattle foreign companies in China, where a series of ...